Literature DB >> 10919708

Functional cloning of ARM-1, an adhesion-regulating molecule upregulated in metastatic tumor cells.

A B Simins1, H Weighardt, K M Weidner, U H Weidle, B Holzmann.   

Abstract

Interactions of tumor cells with the endothelium and tissue stroma are considered to be critical steps in metastasis formation and progression of cancer. To identify cellular receptors that mediate the binding of tumor cells to endothelium, a murine T cell lymphoma-derived expression library was screened for adhesion-inducing cDNA clones. We identified a novel cell adhesion-promoting molecule, termed ARM-1 (adhesion regulating molecule-1), which is homologous to a human Mr 110,000 tumor-associated antigen. The ARM-1 cDNA codes for a type I transmembrane protein of 407 amino acids with potential O- and N-glycosylation sites that does not belong to any of the known families of cell adhesion molecules. Overexpression of ARM-1 in 293T human embryonic kidney cells significantly increased adhesion to different endothelial cells. ARM-1 expression in 293T cells did not alter integrin expression or beta1-integrin-mediated cell adhesion. Northern blot analysis of human breast cancer cell lines revealed 3- to 5-fold elevated ARM-1 mRNA levels in metastatic as compared to non-metastatic cells. In conclusion, we have identified ARM-1 as a novel cell adhesion-promoting receptor that is upregulated in metastatic cancer cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10919708     DOI: 10.1023/a:1006790912877

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  38 in total

Review 1.  Organ-specific requirements for cell adhesion molecules during lymphoma cell dissemination.

Authors:  D Naor; R V Sionov; M Zahalka; M Rochman; B Holzmann; D Ish-Shalom
Journal:  Curr Top Microbiol Immunol       Date:  1998       Impact factor: 4.291

Review 2.  Selectins, T-cell rolling and inflammation.

Authors:  H Rossiter; R Alon; T S Kupper
Journal:  Mol Med Today       Date:  1997-05

3.  O-GLYCBASE version 2.0: a revised database of O-glycosylated proteins.

Authors:  J E Hansen; O Lund; K Rapacki; S Brunak
Journal:  Nucleic Acids Res       Date:  1997-01-01       Impact factor: 16.971

Review 4.  alpha 4 integrins and tumor metastasis.

Authors:  B Holzmann; U Gosslar; M Bittner
Journal:  Curr Top Microbiol Immunol       Date:  1998       Impact factor: 4.291

5.  E-cadherin germline mutations in familial gastric cancer.

Authors:  P Guilford; J Hopkins; J Harraway; M McLeod; N McLeod; P Harawira; H Taite; R Scoular; A Miller; A E Reeve
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

6.  Heterogeneity of mucin gene expression in normal and neoplastic tissues.

Authors:  S B Ho; G A Niehans; C Lyftogt; P S Yan; D L Cherwitz; E T Gum; R Dahiya; Y S Kim
Journal:  Cancer Res       Date:  1993-02-01       Impact factor: 12.701

7.  Differential gene expression in mammary carcinoma cell lines: identification of DRIM, a new gene down-regulated in metastasis.

Authors:  M Schwirzke; A Gnirke; P Bork; D Tarin; U H Weidle
Journal:  Anticancer Res       Date:  1998 May-Jun       Impact factor: 2.480

8.  MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma.

Authors:  S Nakamori; D M Ota; K R Cleary; K Shirotani; T Irimura
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

9.  Beta 2-integrin dependent aggregate formation between LB T cell lymphoma and spleen cells: assessment of correlation with spleen invasiveness.

Authors:  M A Zahalka; D Naor
Journal:  Int Immunol       Date:  1994-06       Impact factor: 4.823

Review 10.  CEA adhesion molecules: multifunctional proteins with signal-regulatory properties.

Authors:  B Obrink
Journal:  Curr Opin Cell Biol       Date:  1997-10       Impact factor: 8.382

View more
  11 in total

1.  A novel proteasome interacting protein recruits the deubiquitinating enzyme UCH37 to 26S proteasomes.

Authors:  Jun Hamazaki; Shun-Ichiro Iemura; Tohru Natsume; Hideki Yashiroda; Keiji Tanaka; Shigeo Murata
Journal:  EMBO J       Date:  2006-09-21       Impact factor: 11.598

2.  A Phg2-Adrm1 pathway participates in the nutrient-controlled developmental response in Dictyostelium.

Authors:  Nathalie Cherix; Romain Froquet; Steve J Charette; Cédric Blanc; François Letourneur; Pierre Cosson
Journal:  Mol Biol Cell       Date:  2006-09-20       Impact factor: 4.138

3.  hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37.

Authors:  Xiao-Bo Qiu; Song-Ying Ouyang; Chao-Jun Li; Shiying Miao; Linfang Wang; Alfred L Goldberg
Journal:  EMBO J       Date:  2006-11-30       Impact factor: 11.598

Review 4.  Structure characterization of the 26S proteasome.

Authors:  Ho Min Kim; Yadong Yu; Yifan Cheng
Journal:  Biochim Biophys Acta       Date:  2010-08-26

5.  Regulation of NF-kappaB activity and inducible nitric oxide synthase by regulatory particle non-ATPase subunit 13 (Rpn13).

Authors:  Tuhina Mazumdar; F Murat Gorgun; Youbao Sha; Alexey Tyryshkin; Shenyan Zeng; Rasmus Hartmann-Petersen; Jakob Ploug Jørgensen; Klavs B Hendil; N Tony Eissa
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-15       Impact factor: 11.205

6.  Regulators of the proteasome pathway, Uch37 and Rpn13, play distinct roles in mouse development.

Authors:  Amin Al-Shami; Kanchan G Jhaver; Peter Vogel; Carrie Wilkins; Juliane Humphries; John J Davis; Nianhua Xu; David G Potter; Brenda Gerhardt; Robert Mullinax; Cynthia R Shirley; Stephen J Anderson; Tamas Oravecz
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

7.  Adrm1 interacts with Atp6v0d2 and regulates osteoclast differentiation.

Authors:  Taesoo Kim; Hyun-Il Ha; Nacksung Kim; Okju Yi; Seoung Hoon Lee; Yongwon Choi
Journal:  Biochem Biophys Res Commun       Date:  2009-10-08       Impact factor: 3.575

8.  Amplification Target ADRM1: Role as an Oncogene and Therapeutic Target for Ovarian Cancer.

Authors:  Marlena S Fejzo; Lee Anderson; Erika M von Euw; Ondrej Kalous; Nuraly K Avliyakulov; Michael J Haykinson; Gottfried E Konecny; Richard S Finn; Dennis J Slamon
Journal:  Int J Mol Sci       Date:  2013-02-01       Impact factor: 5.923

9.  Reduced paxillin expression contributes to the antimetastatic effect of 4-hydroxycoumarin on B16-F10 melanoma cells.

Authors:  Marco A Velasco-Velázquez; Nohemí Salinas-Jazmín; Nicandro Mendoza-Patiño; Juan J Mandoki
Journal:  Cancer Cell Int       Date:  2008-05-20       Impact factor: 5.722

Review 10.  The Role of Glycosylation in Breast Cancer Metastasis and Cancer Control.

Authors:  Alexandra C Kölbl; Ulrich Andergassen; Udo Jeschke
Journal:  Front Oncol       Date:  2015-10-13       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.